United Therapeutics Corp · News · TradingHolo

United Therapeutics Corp · News · TradingHolo

UTHR news

Headlines tagged to this company

Stocktwits Wall Street Wrap: Crocs, Liquidia Win Upgrades While SpaceX Competition And Grocery Woes Put AST SpaceMobile, Albertsons Under Pressure

Stocktwits · 4 d ago

Liquidia adds over 30% on United Thera. settlement; BTIG upgrades

Seeking Alpha · 6 d ago

LQDA Stock Rockets 40% Today – BTIG Calls United Therapeutics Settlement ‘Better Than Best-Case Scenario’

Stocktwits · 6 d ago

This Biotech Stock Surges 37% on Patent Settlement. 'Better Than the Best-Case Scenario.' — Barrons.com

Dow Jones Newswires · 6 d ago

Liquidia surges as United Therapeutics settlement removes key litigation risk

Reuters · 6 d ago

United Therapeutics Enters Settlement Agreement With Liquidia To Resolve Litigation - SEC Filing

Reuters · 6 d ago

Liquidia surges after $381 million settlement with United Therapeutics for lung disease drug

Reuters · 6 d ago

Liquidia Settles All Litigation With United Therapeutics; Shares Rise

dpa-AFX · 6 d ago

United Therapeutics, Liquidia settle patent and related litigation with $330.4M transfer

TradingView · 6 d ago

Key facts: UTHR FDA accepts NDAs; YUTREPIA available; $175M payment

TradingView · 6 d ago

Liquidia rockets 42% as $380.7M deal ends United Therapeutics legal battle

Seeking Alpha · 6 d ago

LQDA Explodes After Hours On Deal Ending Years Of Patent Fight, Keeping YUTREPIA On Market

Stocktwits · 6 d ago

Liquidia to Pay $380.7M to Settle Lawsuits With United Therapeutics

Dow Jones Newswires · 6 d ago

Liquidia Announces Global Settlement Resolving All Pending Litigation With United Therapeutics, Ensuring Continued Commercialization Of Yutrepia In Pah

Reuters · 6 d ago

Liquidia Announces Global Settlement Resolving All Pending Litigation with United Therapeutics, Ensuring Continued Commercialization of YUTREPIA in PAH

GlobeNewswire · 6 d ago

United Therapeutics Presents New Data at the CHEST 2026 Annual Meeting

BusinessWire · 7 d ago

United Therapeutics Is Maintained at Outperform by RBC Capital

Dow Jones Newswires · 12 d ago

United Therapeutics Price Target Raised to $566.00/Share From $515.00 by Morgan Stanley

Dow Jones Newswires · 13 d ago

Top 10 Q3 insider stock sellers led by Nvidia’s Stevens, Jeff Bezos

Seeking Alpha · 13 d ago

Liquidia extends losses as Wells Fargo adds to downgrades on legal setback

Seeking Alpha · 18 d ago